509 related articles for article (PubMed ID: 8640404)
1. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
[TBL] [Abstract][Full Text] [Related]
2. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia.
Guérin M; Dolphin PJ; Talussot C; Gardette J; Berthézène F; Chapman MJ
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1359-68. PubMed ID: 7670950
[TBL] [Abstract][Full Text] [Related]
5. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
7. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
Le Goff W; Guerin M; Chapman MJ
Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
[TBL] [Abstract][Full Text] [Related]
9. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
10. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
van der Hoogt CC; de Haan W; Westerterp M; Hoekstra M; Dallinga-Thie GM; Romijn JA; Princen HM; Jukema JW; Havekes LM; Rensen PC
J Lipid Res; 2007 Aug; 48(8):1763-71. PubMed ID: 17525476
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
Riemens S; van Tol A; Sluiter W; Dullaart R
Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
[TBL] [Abstract][Full Text] [Related]
15. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
[TBL] [Abstract][Full Text] [Related]
16. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
Contacos C; Barter PJ; Vrga L; Sullivan DR
Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA
Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.
Lagrost L; Athias A; Herbeth B; Guyard-Dangremont V; Artur Y; Paille F; Gambert P; Lallemant C
J Biol Chem; 1996 Aug; 271(32):19058-65. PubMed ID: 8702577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
